Clinical Trial Update: Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial compares the combination of trifluridine/tipiracil plus fruquintinib versus trifluridine/tipiracil alone in metastatic esophagogastric adenocarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Adenocarcinoma

Drugs mentioned

• Fruquintinib (fruquintinib)
• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Metastatic Oesogastric Adenocarcinoma | Phase 3 | Status: RECRUITING